Bhuvana A. Setty

801 total citations
45 papers, 492 citations indexed

About

Bhuvana A. Setty is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Bhuvana A. Setty has authored 45 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Bhuvana A. Setty's work include Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (7 papers) and Tumors and Oncological Cases (6 papers). Bhuvana A. Setty is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (7 papers) and Tumors and Oncological Cases (6 papers). Bhuvana A. Setty collaborates with scholars based in United States, Canada and Taiwan. Bhuvana A. Setty's co-authors include Bryce A. Kerlin, Sarah H. O’Brien, Nicholas D. Yeager, Damon R. Reed, Peter J. Houghton, Leo Mascarenhas, Ryan D. Roberts, Anthony Audino, Steven G. DuBois and Yi Jin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bhuvana A. Setty

39 papers receiving 486 citations

Peers

Bhuvana A. Setty
Megan Elfline United States
S. Osanto Netherlands
Jelena Bila Serbia
Konstantin Schlick Austria
D Guyotat France
Sherin Alias Austria
B. Dörken Germany
Maurits L. van Montfoort Netherlands
Walter Kisiel United States
Abraham Avigdor Israel
Megan Elfline United States
Bhuvana A. Setty
Citations per year, relative to Bhuvana A. Setty Bhuvana A. Setty (= 1×) peers Megan Elfline

Countries citing papers authored by Bhuvana A. Setty

Since Specialization
Citations

This map shows the geographic impact of Bhuvana A. Setty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhuvana A. Setty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhuvana A. Setty more than expected).

Fields of papers citing papers by Bhuvana A. Setty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhuvana A. Setty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhuvana A. Setty. The network helps show where Bhuvana A. Setty may publish in the future.

Co-authorship network of co-authors of Bhuvana A. Setty

This figure shows the co-authorship network connecting the top 25 collaborators of Bhuvana A. Setty. A scholar is included among the top collaborators of Bhuvana A. Setty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhuvana A. Setty. Bhuvana A. Setty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upadhyay, Rituraj, Brett Klamer, Raj Singh, et al.. (2025). Local Control and Toxicity Outcomes After Stereotactic Body Radiation Therapy for Metastatic Osteosarcoma in Pediatric Patients. Pediatric Blood & Cancer. 72(9). e31834–e31834.
2.
Schieffer, Kathleen M., Bhuvana A. Setty, Margot Lazow, et al.. (2025). Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings. JCO Precision Oncology. 9(9). e2400910–e2400910.
3.
Heske, Christine M., Filemon S. Dela Cruz, Sarah Burkhead Whittle, et al.. (2025). New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee. Pediatric Blood & Cancer. 72(10). e31917–e31917.
4.
Shulman, David S., Kelly Klega, Nan Chen, et al.. (2024). Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.. Journal of Clinical Oncology. 42(16_suppl). 11510–11510. 1 indexed citations
5.
Gupta, Abha A., Bhuvana A. Setty, Mary Frances Wedekind, et al.. (2024). Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatric Blood & Cancer. 72(3). e31477–e31477.
6.
Upadhyay, Rituraj, Brett Klamer, Jennifer K. Matsui, et al.. (2024). Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers. 16(11). 2090–2090. 2 indexed citations
7.
Koo, Selene C., Kathleen M. Schieffer, Kristy Lee, et al.. (2022). EGFR internal tandem duplications in fusion‐negative congenital and neonatal spindle cell tumors. Genes Chromosomes and Cancer. 62(1). 17–26. 3 indexed citations
8.
Abdelbaki, Mohamed S, Timothy P. Cripe, Richard Curry, et al.. (2022). An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 8(12). e12450–e12450. 2 indexed citations
9.
Setty, Bhuvana A., Katie Wusik, & Adrienne M. Hammill. (2022). How we approach genetics in the diagnosis and management of vascular anomalies. Pediatric Blood & Cancer. 69(S3). e29320–e29320. 12 indexed citations
10.
Halsey, Jordan N., Esteban Fernández Faith, Suzanna Logan, et al.. (2022). Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Reports in Dermatological Medicine. 2022. 1–5. 7 indexed citations
11.
Baliga, Sujith, Jennifer K. Matsui, Brett Klamer, et al.. (2022). Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. British Journal of Radiology. 95(1133). 20211088–20211088. 3 indexed citations
12.
Young, J. P. R., Bhuvana A. Setty, Adam Lane, et al.. (2021). Chemotherapy‐induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatric Blood & Cancer. 69(7). e29548–e29548. 5 indexed citations
13.
Oesterheld, Javier, Damon R. Reed, Bhuvana A. Setty, et al.. (2020). Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatric Blood & Cancer. 67(7). e28370–e28370. 16 indexed citations
14.
Setty, Bhuvana A., Goodwin G. Jinesh, Michael Arnold, et al.. (2020). The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genetics. 16(4). e1008642–e1008642. 25 indexed citations
15.
16.
Setty, Bhuvana A., et al.. (2017). VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatric Blood & Cancer. 65(1). 27 indexed citations
17.
Sulkowski, Jason P., Kathleen Nicol, Mehul V. Raval, et al.. (2014). Infantile fibrosarcoma of the intestine: A report of two cases and literature review. Journal of Pediatric Surgery Case Reports. 2(6). 290–293. 1 indexed citations
18.
Setty, Bhuvana A., Nicholas D. Yeager, & Rajinder Bajwa. (2011). Heterozygous M1V variant of ELA‐2 gene mutation associated with G‐CSF refractory severe congenital neutropenia. Pediatric Blood & Cancer. 57(3). 514–515. 8 indexed citations
19.
Setty, Bhuvana A., Sarah H. O’Brien, & Bryce A. Kerlin. (2011). Pediatric venous thromboembolism in the United States: A tertiary care complication of chronic diseases. Pediatric Blood & Cancer. 59(2). 258–264. 144 indexed citations
20.
Setty, Bhuvana A. & Amanda Termuhlen. (2010). Rare Pediatric Non-Hodgkin Lymphoma. Current Hematologic Malignancy Reports. 5(3). 163–168. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan Elfline Breakdown of academic impact, for papers by S. Osanto Breakdown of academic impact, for papers by Jelena Bila Breakdown of academic impact, for papers by Konstantin Schlick Breakdown of academic impact, for papers by D Guyotat Breakdown of academic impact, for papers by Sherin Alias Breakdown of academic impact, for papers by B. Dörken Breakdown of academic impact, for papers by Maurits L. van Montfoort Breakdown of academic impact, for papers by Walter Kisiel Breakdown of academic impact, for papers by Abraham Avigdor
Rankless by CCL
2026